Abdul Miah

Abdul Miah's work centers on clinical oncology, particularly treatment outcomes and survival in cancers such as breast cancer, renal cell carcinoma, and brain/leptomeningeal metastases. Much of the research examines how immune-based therapies (like immune checkpoint inhibitors) and chemotherapy affect patient outcomes, often through multicenter or registry-based studies. This work would suit students interested in clinical cancer research, treatment outcome analysis, and immunotherapy.

Publication output rose sharply to a peak in 2021 and has since declined to a slower, steadier pace in recent years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026